Affordable Access

[Systemic chemotherapy and chemoradiotherapy for advanced pancreatic cancer].

Authors
  • 1
  • 1 Hepatobiliary and Pancreatic Oncology Division, National Cancer Center Hospital, Tokyo, Japan. , (Japan)
Type
Published Article
Journal
Gan to kagaku ryoho. Cancer & chemotherapy
Publication Date
Volume
39
Issue
3
Pages
357–363
Identifiers
PMID: 22421761
Source
Medline
License
Unknown

Abstract

Currently, we are able to use S-1 with gemcitabine and erlotinib, as well as gemcitabine alone, as first-line therapy for advanced pancreatic cancer. In addition, a clinical trial of FOLFIRINOX is underway in Japan. On the other hand, chemoradiotherapy is considered to be one of the treatments of choice for locally advanced pancreatic cancer. This review summarizes current knowledge about non-surgical treatment for advanced pancreatic cancer, mainly based on the results of recent clinical trials.

Statistics

Seen <100 times